2018
Effectiveness of a community-based educational programme in reducing the cumulative incidence and prevalence of human Taenia solium cysticercosis in Burkina Faso in 2011–14 (EFECAB): a cluster-randomised controlled trial
Carabin H, Millogo A, Ngowi H, Bauer C, Dermauw V, Koné A, Sahlu I, Salvator A, Preux P, Somé T, Tarnagda Z, Gabriël S, Cissé R, Ouédraogo J, Cowan L, Boncoeur-Martel M, Dorny P, Ganaba R. Effectiveness of a community-based educational programme in reducing the cumulative incidence and prevalence of human Taenia solium cysticercosis in Burkina Faso in 2011–14 (EFECAB): a cluster-randomised controlled trial. The Lancet Global Health 2018, 6: e411-e425. PMID: 29530423, PMCID: PMC5873982, DOI: 10.1016/s2214-109x(18)30027-5.Peer-Reviewed Original ResearchConceptsCumulative incidenceHuman cysticercosisActive cysticercosisHuman Taenia solium cysticercosisCommunity-based educational interventionDrug-free interventionsTaenia solium transmissionCommunity-based educational programTaenia solium cysticercosisLow-resource settingsPrevalence of cysticercosisEligible villagesPrimary outcomeUS National InstitutesSolium transmissionBlood samplesFinal sample sizeControl groupSolium cysticercosisCysticercosisCysticercosis prevalenceRandomisationEducational interventionPrevalenceIncidence
2016
Comparison of Preventive and Therapeutic Zinc Supplementation in Young Children in Burkina Faso: A Cluster-Randomized, Community-Based Trial 1–3
Becquey E, Ouédraogo C, Hess S, Rouamba N, Prince L, Ouédraogo J, Vosti S, Brown K. Comparison of Preventive and Therapeutic Zinc Supplementation in Young Children in Burkina Faso: A Cluster-Randomized, Community-Based Trial 1–3. Journal Of Nutrition 2016, 146: 2058-2066. PMID: 27489011, DOI: 10.3945/jn.116.230128.Peer-Reviewed Original ResearchConceptsTherapeutic zinc supplementationPreventive zinc supplementationZinc supplementationNonintervention controlsMalaria incidenceDiarrhea incidenceZinc-deficient populationsPrevalence of diarrheaPlasma zinc concentrationTreatment of diarrheaPrimary outcomeBurkinabe childrenMSC groupLower incidenceNIC groupStudy groupTreatment groupsPrimary analysisControl groupDiarrheaIncidenceSupplementationTrial 1Young childrenFever